advertisement

Topcon

Zhang J 9

Showing records 1 to 9 | Display all abstracts from Zhang J

98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Niu F
eLife 2022; 11:
98454 Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population
Gruzei C
International Ophthalmology 2022; 42: 785-797
99369 Real-Time Monitoring of Intraocular Pressure in Glaucoma Patients Using Wearable Mobile Medicine Devices
Yuan X
Journal of healthcare engineering 2022; 2022: 2271937
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Han P
eLife 2022; 11:
99369 Real-Time Monitoring of Intraocular Pressure in Glaucoma Patients Using Wearable Mobile Medicine Devices
Zhang J
Journal of healthcare engineering 2022; 2022: 2271937
98454 Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population
Zhang J
International Ophthalmology 2022; 42: 785-797
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Zhang J
eLife 2022; 11:
98454 Testing the eligibility of glaucoma patients for potential gene therapy among a clinic population
Bourne R
International Ophthalmology 2022; 42: 785-797
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
She Y; Yang L; Yu J; Zhuang M; Tang K; Shi Y; Yang B; Liu C; Peng B; Ji SJ
eLife 2022; 11:

Issue 22-4

Change Issue


advertisement

Nidek